2026
在技術研發層面，吉晟生技持續深耕神經科學領域，針對巴金森氏症及失智症相關的核醫診斷試劑已取得穩定進展。
同時，公司積極與產業夥伴展開戰略協作，包括與嘉正生技合作開發抗體放射複合體（ARC），以及支援禾榮科技之硼中子捕獲治療（BNCT）所需的關鍵檢測藥品。透過這類「診療一體化」的策略整合，吉晟生技正逐步建構起多元化的產品矩陣，提升在精準醫療市場的長期競爭力。
In compliance with EU personal data protection laws, we are committed to protecting and providing you with control over your personal data. By clicking "Accept All", you allow us to place cookies to enhance your experience on this site, help us analyze site performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. By clicking "Agree" you agree to the current settings. For more information, please visit the Privacy Statement.
This website uses cookies
In compliance with EU personal data protection laws, we are committed to protecting your personal data and providing you with control over it. By clicking "Agree", you allow us to place cookies to improve your experience on this site, help us analyze site performance and usage, and allow us to deliver relevant marketing content.
By clicking "Only necessary" you allow us to place only necessary cookies. The website cannot function without these cookies and you cannot switch them off on your system. These cookies are typically set only in response to an action you perform (i.e. a service request), such as setting privacy preferences, logging in, or filling in a form. You can set your browser to block or prompt you for these cookies, but this may prevent some site features from working.
